Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
(HAM/TSP) is a progressive disease of the CNS that causes weakness or paralysis of the …

Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately
10–20 million people worldwide. While the majority of infected people are asymptomatic …

Around ten million people are infected with HTLV-1 worldwide, and 1–4% develop HTLV-1-
associated myelopathy/tropical spastic paraparesis (HAM/TSP), characterized by an …

The human T-cell lymphotropic virus type 1 (HTLV-1) infects 5-10 million people worldwide
and causes fatal and disabling diseases in a significant proportion of them. A chronic …

HTLV-1–associated myelopathy (HAM/TSP) is a chronic and progressive inflammatory
disease of the central nervous system. The aim of our study was to identify genetic …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

Background HTLV-1 infection is a neglected disease. Over 10 million people are infected
worldwide, with hot spots of high endemicity across all continents. Roughly 5% of HTLV-1 …

Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a neurological disorder presenting with spastic paraparesis …

The reasons that lead some individuals living with the Human T Lymphotropic Virus 1 (HTLV‐
1) to develop HAM/TSP are still unclear. To better understand the viral genetic factors that …

Background Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of
HTLV associated myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell …